Menter Alan
Chief, Division of Dermatology, Baylor University Medical Center; Clinical Professor of Dermatology, University of Texas, Southwestern Medical School; Director, Fellowship Program, Baylor Psoriasis Center; Chair, Psoriasis Guidelines Committee, American Academy of Dermatology; Director, Dermatology Residency Program, Baylor University Medical Center, Dallas, TX.
Semin Cutan Med Surg. 2014 Jun;33(3 Suppl):S54-6. doi: 10.12788/j.sder.0093.
The list of comorbidities associated with hidradenitis suppurativa (HS) is extensive, although these diseases do not necessarily share a common causality. Among the categories of comorbidities that are observed are obesity, other skin diseases, inflammatory conditions, and genetic disorders. Complications include scarring, restricted movement resulting from scarring and fibrosis in underlying tissue, conditions associated with obstructed lymph drainage, and psychosocial issues. Adverse effects on quality of life are common and may be severe, including unemployment, deterioration of family and other social relationships, and suicidal ideation. Clinical intervention for HS must include consideration and attention to these comorbidities and complications.
与化脓性汗腺炎(HS)相关的合并症清单很长,尽管这些疾病不一定有共同的因果关系。观察到的合并症类别包括肥胖、其他皮肤病、炎症性疾病和遗传性疾病。并发症包括瘢痕形成、因潜在组织瘢痕形成和纤维化导致的活动受限、与淋巴引流受阻相关的病症以及心理社会问题。对生活质量的不良影响很常见,而且可能很严重,包括失业、家庭及其他社会关系恶化以及自杀念头。HS的临床干预必须包括对这些合并症和并发症的考虑及关注。